Caitlin John, LLC Fate Therapeutics Inc Transaction History
Caitlin John, LLC
- $160 Billion
- Q3 2024
A detailed history of Caitlin John, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Caitlin John, LLC holds 92 shares of FATE stock, worth $149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92Holding current value
$149% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FATE
# of Institutions
175Shares Held
115MCall Options Held
53.7KPut Options Held
9K-
Redmile Group, LLC San Francisco, CA13.2MShares$21.3 Million3.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$16.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$16.4 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.57MShares$9.03 Million0.72% of portfolio
-
State Street Corp Boston, MA5.25MShares$8.51 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $157M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...